Cargando…

Cardiovascular Protection of Hydroxychloroquine in Patients with Sjögren’s Syndrome

Sjögren’s syndrome (SS) is a chronic systemic inflammation disease with clinical presentation of dry eye, dry mouth, and polyarthralgia. Active inflammation is associated with an increased risk of associated arterial stiffness or subclinical atherosclerosis-related cardiovascular events. We used the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Deng-Ho, Wang, Yu-Hsun, Pan, Lung-Fa, Wei, James Cheng-Chung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694056/ https://www.ncbi.nlm.nih.gov/pubmed/33126508 http://dx.doi.org/10.3390/jcm9113469

Ejemplares similares

Is hydroxychloroquine effective in treating primary Sjogren’s syndrome: a systematic review and meta-analysis
por: Wang, Shi-Qin, et al.
Publicado: (2017)

Cutaneous purpura of Sjögren syndrome successfully treated with hydroxychloroquine
por: Hile, Grace A., et al.
Publicado: (2017)

Ocular microvascular alteration in Sjögren’s syndrome treated with hydroxychloroquine: an OCTA clinical study
por: Yu, Chao, et al.
Publicado: (2023)

Hydroxychloroquine and risk of cancer in patients with primary Sjögren syndrome: propensity score matched landmark analysis
por: Fang, Yao-Fan, et al.
Publicado: (2017)

Long-Term Hydroxychloroquine Therapy and Risk of Coronary Artery Disease in Patients with Systemic Lupus Erythematosus
por: Yang, Deng-Ho, et al.
Publicado: (2019)

Nontypeable Hemophilus Influenza Meningitis in a Primary Sjögren's Syndrome Patient on Hydroxychloroquine
por: Yassa, Gizem, et al.
Publicado: (2023)

The Efficiency of Hydroxychloroquine for the Treatment of Primary Sjögren’s Syndrome: A Systematic Review and Meta-Analysis
por: Wang, Xuan, et al.
Publicado: (2021)

Hydroxychloroquine is neutral on incidental cataracts in patients with rheumatoid arthritis
por: Zhang, Zhibo, et al.
Publicado: (2023)

Revisiting the JOQUER trial: stratification of primary Sjögren’s syndrome and the clinical and interferon response to hydroxychloroquine
por: Collins, Alexis, et al.
Publicado: (2021)

Sweet’s Syndrome Following Therapy with Hydroxychloroquine in a Patient Affected with Elderly-Onset Primary Sjogren’s Syndrome
por: Manzo, Ciro, et al.
Publicado: (2019)

Increased Risk of Sjögren’s Syndrome in Patients with Obsessive-Compulsive Disorder: A Nationwide Population-Based Cohort Study
por: Chang, Yi-Jung, et al.
Publicado: (2021)

Cardiovascular Involvement in Sjögren’s Syndrome
por: Atzeni, Fabiola, et al.
Publicado: (2022)

Hydroxychloroquine treatment downregulates systemic interferon activation in primary Sjögren’s syndrome in the JOQUER randomized trial
por: Bodewes, Iris L A, et al.
Publicado: (2020)

Combined use of total glucosides of paeony and hydroxychloroquine in primary Sjögren's syndrome: A systematic review
por: Zhang, Aiping, et al.
Publicado: (2023)

Relationship of Hydroxychloroquine and Ophthalmic Complications in Patients with Type 2 Diabetes in Taiwan
por: Chen, Hung-Chih, et al.
Publicado: (2021)

Effect of Hydroxychloroquine Treatment on Dry Eyes in Subjects with Primary Sjögren’s Syndrome: a Double-Blind Randomized Control Study
por: Yoon, Chang Ho, et al.
Publicado: (2016)

Hydroxychloroquine and the treatment of Sjogren syndrome, chronic ulcerative stomatitis, and oral lichen planus in the age of COVID-19
por: Hussein, Heba, et al.
Publicado: (2021)

Impact of Sjogren's syndrome on Parkinson’s disease: A nationwide case-control study
por: Wu, Ming-Chi, et al.
Publicado: (2017)

Lady Windermere syndrome in Sjögren’s syndrome
por: Pan, Yu-Ling, et al.
Publicado: (2018)

Protection by hydroxychloroquine prevents placental injury in obstetric antiphospholipid syndrome
por: Liu, Jing, et al.
Publicado: (2022)

Cardiovascular Risk Factors in Women With Primary Sjögren's Syndrome: United Kingdom Primary Sjögren's Syndrome Registry Results
por: Juarez, M, et al.
Publicado: (2014)

Premature stroke and cardiovascular risk in primary Sjögren's syndrome
por: Zippel, Clara L., et al.
Publicado: (2022)

Hydroxychloroquine and Cardiovascular Events in Patients with Rheumatoid Arthritis
por: Cordova Sanchez, Andres, et al.
Publicado: (2022)

Cardiovascular Disease in Primary Sjögren’s Syndrome: Raising Clinicians’ Awareness
por: Casian, Mihnea, et al.
Publicado: (2022)

Association Between Endometriosis and Subsequent Risk of Sjögren’s Syndrome: A Nationwide Population-Based Cohort Study
por: Chao, Yung-Hsiang, et al.
Publicado: (2022)

Altered subgroups of regulatory T cells in patients with primary Sjögren's syndrome
por: Lin, Jing-Chi, et al.
Publicado: (2023)

Higher Risk for Sjögren’s Syndrome in Patients With Fibromyalgia: A Nationwide Population-Based Cohort Study
por: Gau, Shuo-Yan, et al.
Publicado: (2021)

Sjögren’s syndrome
por: André, Fiona, et al.
Publicado: (2022)

Revisiting the cardiovascular risk of hydroxychloroquine in RA
por: Pers, Yves-Marie, et al.
Publicado: (2020)

Hydroxychloroquine- and chloroquine-related cardiovascular events
Publicado: (2020)

Recurrent Severe Hyponatremia in a Patient with Sjögren's Syndrome
por: Kim, Hyung Duk, et al.
Publicado: (2020)

Exposure to environmental air pollutants as a risk factor for primary Sjögren’s syndrome
por: Ma, Kevin Sheng-Kai, et al.
Publicado: (2023)

Association of hydroxychloroquine and cardiac arrhythmia in patients with systemic lupus erythematosus: A population-based case control study
por: Lo, Chien-Hsien, et al.
Publicado: (2021)

The Effect of Hydroxychloroquine on Cardiovascular Disease in Patients with Rheumatoid Arthritis
por: Mo, De-Gang, et al.
Publicado: (2022)

Leflunomide/hydroxychloroquine combination therapy targets type I IFN-associated proteins in patients with Sjögren’s syndrome that show potential to predict and monitor clinical response
por: Hamkour, Safae, et al.
Publicado: (2023)

A Glimpse Into the Microbiome of Sjögren’s Syndrome
por: Deng, Chuiwen, et al.
Publicado: (2022)

Infectious Keratitis in Patients with Ocular Sjögren’s Syndrome
por: Kim, So Yeon, et al.
Publicado: (2022)

Rituximab Therapy for Primary Sjögren’s Syndrome
por: Chen, Yi Han, et al.
Publicado: (2021)

Clinical Outcomes of Cataract Surgery in Patients with Sjögren’s Syndrome
por: Lee, Donghyeon, et al.
Publicado: (2022)

Contribution of Genetic Factors to Sjögren's Syndrome and Sjögren's Syndrome Related Lymphomagenesis
por: Nezos, Adrianos, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_i4uke6ur5g7ct1ihh93i33r7nk